Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


03.10.2017

1 Arch Virol
1 J Infect
4 J Virol
1 JAMA
1 Lancet Infect Dis
3 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Pediatr Infect Dis J
4 PLoS One
1 Science
23 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. TURMAGAMBETOVA AS, Alexyuk PG, Bogoyavlenskiy AP, Zaitseva IA, et al
    Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
    Arch Virol. 2017 Sep 21. doi: 10.1007/s00705-017-3560.
    PubMed     Text format     Abstract available


    J Infect

  2. RONDY M, El Omeiri N, Thompson MG, Leveque A, et al
    Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.
    J Infect. 2017 Sep 18. pii: S0163-4453(17)30299.
    PubMed     Text format     Abstract available


    J Virol

  3. PHAN SI, Zengel JR, Wei H, Li Z, et al
    Parainfluenza virus 5 (PIV5) expressing wild-type or pre-fusion respiratory syncytial virus (RSV) fusion protein protect mice and cotton rats from RSV challenge.
    J Virol. 2017 Jul 26. pii: JVI.00560-17. doi: 10.1128/JVI.00560.
    PubMed     Text format     Abstract available

  4. URAKAMI A, Ngwe Tun MM, Moi ML, Sakurai A, et al
    Envelope-modified tetravalent dengue virus-like particle vaccine: implication for flavivirus vaccine design.
    J Virol. 2017 Sep 27. pii: JVI.01181-17. doi: 10.1128/JVI.01181.
    PubMed     Text format     Abstract available

  5. BAGRI P, Anipindi VC, Nguyen PV, Vitali D, et al
    A novel role for IL-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal HSV-2 vaccination.
    J Virol. 2017 Sep 27. pii: JVI.01234-17. doi: 10.1128/JVI.01234.
    PubMed     Text format     Abstract available

  6. GOFF PH, Hayashi T, He W, Yao S, et al
    Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    JAMA

  7. LOWY DR, Schiller JT
    Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection: 2017 Lasker-DeBakey Clinical Research Award.
    JAMA. 2017;318:901-902.
    PubMed     Text format    


    Lancet Infect Dis

  8. THE LANCET INFECTIOUS DISEASES
    Vaccine against Zika virus must remain a priority.
    Lancet Infect Dis. 2017;17:1003.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep


  9. Announcement: Final 2016-17 Influenza Vaccination Coverage Estimates Available Online.
    MMWR Morb Mortal Wkly Rep. 2017;66:1028.
    PubMed     Text format    

  10. BLACK CL, Yue X, Ball SW, Fink R, et al
    Influenza Vaccination Coverage Among Health Care Personnel - United States, 2016-17 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2017;66:1009-1015.
    PubMed     Text format     Abstract available

  11. DING H, Black CL, Ball S, Fink RV, et al
    Influenza Vaccination Coverage Among Pregnant Women - United States, 2016-17 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2017;66:1016-1022.
    PubMed     Text format     Abstract available


    N Engl J Med

  12. HOLLAND SM, Pierce VM, Shailam R, Glomski K, et al
    Case 28-2017. A 13-Month-Old Girl with Pneumonia and a 33-Year-Old Woman with Hip Pain.
    N Engl J Med. 2017;377:1077-1091.
    PubMed     Text format    


    Pediatr Infect Dis J

  13. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
    Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
    Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
    PubMed     Text format     Abstract available

  14. BERNAOLA E, Gil F, Herranz M, Gil-Setas A, et al
    Pneumococcal Vaccination and Pneumonia Associated with Pleural Effusion in a Pediatric Population.
    Pediatr Infect Dis J. 2017 Sep 20. doi: 10.1097/INF.0000000000001798.
    PubMed     Text format     Abstract available


    PLoS One

  15. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    PubMed     Text format     Abstract available

  16. GRIMALDI G JR, Teva A, Dos-Santos CB, Santos FN, et al
    Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    PLoS One. 2017;12:e0185438.
    PubMed     Text format     Abstract available

  17. FABURAY B, McGill J, Jongejan F
    A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.
    PLoS One. 2017;12:e0185495.
    PubMed     Text format     Abstract available

  18. VINOD N, Noh HB, Oh S, Ji S, et al
    A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.
    PLoS One. 2017;12:e0185488.
    PubMed     Text format     Abstract available


    Science

  19. COHEN J
    Why is the flu vaccine so mediocre?
    Science. 2017;357:1222-1223.
    PubMed     Text format    


    Vaccine

  20. TSENG CW, Chiu CJ, Kanci A, Noormohammadi AH, et al
    Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate.
    Vaccine. 2017 Sep 20. pii: S0264-410X(17)31171.
    PubMed     Text format     Abstract available

  21. VENKATRAMAN N, Anagnostou N, Bliss C, Bowyer G, et al
    Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M.
    Vaccine. 2017 Sep 20. pii: S0264-410X(17)31248.
    PubMed     Text format     Abstract available

  22. PARK J, Goldstein J, Haran M, Ferrari M, et al
    An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger.
    Vaccine. 2017;35:5835-5841.
    PubMed     Text format     Abstract available

  23. PUIG-BARBERA J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015.
    Vaccine. 2017;35:5799-5807.
    PubMed     Text format     Abstract available

  24. KARAN D
    Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.
    Vaccine. 2017;35:5794-5798.
    PubMed     Text format     Abstract available

  25. WANG J, Qiu J, Zhu Y, Zhou H, et al
    Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Vaccine. 2017;35:5808-5813.
    PubMed     Text format     Abstract available

  26. MO Z, Mo Y, Li M, Tao J, et al
    Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.
    Vaccine. 2017;35:5897-5904.
    PubMed     Text format     Abstract available

  27. GEE J, Sukumaran L, Weintraub E
    Risk of Guillain-Barre Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink.
    Vaccine. 2017;35:5756-5758.
    PubMed     Text format     Abstract available

  28. HANSEN J, Zhang L, Klein NP, Robertson CA, et al
    Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.
    Vaccine. 2017 Sep 20. pii: S0264-410X(17)31259.
    PubMed     Text format     Abstract available

  29. SIRIMA SB, Durier C, Kara L, Houard S, et al
    Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel(R) in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
    Vaccine. 2017 Sep 22. pii: S0264-410X(17)31247.
    PubMed     Text format     Abstract available

  30. ZIMMERMAN RK, Raviotta JM, Nowalk MP, Moehling KK, et al
    Using the 4 Pillars Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Vaccine. 2017 Sep 22. pii: S0264-410X(17)31268.
    PubMed     Text format     Abstract available

  31. VALLEE-TOURANGEAU G, Promberger M, Moon K, Wheelock A, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: Development and validation of two short scales.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31092.
    PubMed     Text format     Abstract available

  32. KANDEIL A, Mostafa A, El-Shesheny R, El-Taweel AN, et al
    Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31269.
    PubMed     Text format     Abstract available

  33. GOUJON C, Gougeon ML, Tondeur L, Poirier B, et al
    CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31295.
    PubMed     Text format     Abstract available

  34. HALSEY NA, Proveaux T
    Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31297.
    PubMed     Text format     Abstract available

  35. LOW MSF, Tan H, Hartman M, Tam CC, et al
    Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31308.
    PubMed     Text format     Abstract available

  36. FINNEY RUTTEN LJ, St Sauver JL, Beebe TJ, Wilson PM, et al
    Association of both consistency and strength of self-reported clinician recommendation for HPV vaccination and HPV vaccine uptake among 11- to 12-year-old children.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31304.
    PubMed     Text format     Abstract available

  37. RAHAJAMANANA VL, Raboba JL, Rakotozanany A, Razafindraibe NJ, et al
    Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31205.
    PubMed     Text format     Abstract available

  38. SCHIFFER JT, Gottlieb SL
    Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31273.
    PubMed     Text format     Abstract available

  39. COX AD, Williams D, Cairns C, St Michael F, et al
    Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31303.
    PubMed     Text format     Abstract available

  40. JACOBS DM, Yung F, Hart E, Nguyen MNH, et al
    Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31298.
    PubMed     Text format     Abstract available

  41. KIM SY, Nguyen C, Russell LB, Tomczyk S, et al
    Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31185.
    PubMed     Text format     Abstract available

  42. MAYERS J, Mansfield KL, Brown IH
    The role of vaccination in risk mitigation and control of Newcastle disease in poultry.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31223.
    PubMed     Text format     Abstract available


    Virology

  43. KHUPERKAR D, Kamble A, Singh A, Ghate A, et al
    Selective recruitment of nucleoporins on vaccinia virus factories and the role of Nup358 in viral infection.
    Virology. 2017;512:151-160.
    PubMed     Text format     Abstract available

  44. GALAN-NAVARRO C, Rincon-Restrepo M, Zimmer G, Ollmann Saphire E, et al
    Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein.
    Virology. 2017;512:161-171.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: